Results 231 to 240 of about 1,036,369 (318)

Extended Curettage for Local Control of Chondromyxoid Fibroma: A 33‐Year Experience at a Single Tertiary Center

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The management of chondromyxoid fibroma (CMF) primarily relies on surgical resection, but simple curettage is reportedly associated with a high local recurrence rate. While extended curettage with high‐speed burring effectively manages other locally aggressive bone tumors, its effectiveness for CMF remains unclear. We
Liuzhe Zhang   +6 more
wiley   +1 more source

Multimodal Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma (PDAC) With Vascular Involvement: What Is the Impact of Radiation on Perioperative Outcomes, Local Control, and Survival?

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Objectives Neoadjuvant chemoradiation for PDAC with vascular invasion remains understudied. The aim of this study is to compare neoadjuvant chemotherapy with chemoradiation (NAC + CRT) versus neoadjuvant chemotherapy (NAC) for PDAC with vascular involvement.
Dhruv J. Patel   +14 more
wiley   +1 more source

Rethinking Age Limits in Oncoplastic Breast Surgery: Long‐Term Outcomes of Oncoplastic Surgery in Elderly Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Methods Although OBS is a well‐established approach, evidence regarding its long‐term safety and outcomes in older women remains limited. We performed a retrospective analysis to identify patients ≥ 60 years who underwent OBS for breast cancer between 2001 and 2014.
Francesca De Lorenzi   +9 more
wiley   +1 more source

Chemotherapy After Resection of Pancreatic Ductal Adenocarcinoma: Impact of Different Regimens in a Real‐World Population

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction The PRODIGE 24/CCTG PA.6‐ trial has shown an overall survival (OS) up to 55 months in patients treated with (modified) 5‐fluorouracil, leucovorin, irinotecan and oxaliplatin ((m)FOLFIRINOX) chemotherapy after resection of pancreatic ductal adenocarcinoma (PDAC). The applicability of these results to a real‐world patient population
N. C. Biesma   +7 more
wiley   +1 more source

Background and oncological impact of intraoperative joint fluid leakage during extra-articular osteosarcoma resection. [PDF]

open access: yesSci Rep
Funauchi Y   +7 more
europepmc   +1 more source

Morbidity and Mortality of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients Aged 70 Years and Older: A Two‐Center 10‐Year Experience

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is established for peritoneal surface malignancies, but its use in older patients is debated. We assessed CRS‐HIPEC morbidity and mortality in patients aged ≥ 70 years using a cohort of younger patients as a comparator.
Ali Ediz Kıvanç   +4 more
wiley   +1 more source

A Unique WHSC1L1-FGFR1 Fusion in Follicular Dendritic Cell Sarcoma. [PDF]

open access: yesPathol Int
Farrajota Neves da Silva P   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy